You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatic chemoembolization

Showing 1 - 25 of 3,243
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial (Donafenib, TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 8, 2022

Imatinib With Hepatic Resection or Other Local Treatment for

Completed
  • GIST, Malignant
  • Liver Metastases
  • imatinib (IM)
  • +3 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023

Colorectal Tumors Malignant Trial in Philadelphia (Axitinib 5 MG, Hydroxychloroquine Pill, trans arterial chemoembolization)

Recruiting
  • Colorectal Neoplasms Malignant
  • Axitinib 5 MG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
May 2, 2022

Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Portal Hypertension
  • TACE ± Systemic therapy
  • Nanjing, China
  • +1 more
Jan 28, 2023

Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE-HACI, plus atezolizumab-bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

Not yet recruiting
  • HCC
  • +3 more
  • (no location specified)
Aug 28, 2021

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023

Unresectable Hepatocelluar Carcinoma Receiving Stereotactic

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Conversion
    • (no location specified)
    Sep 15, 2021

    Pain Control, Liver Cancer Trial (Hepatic Hilar Nerve Block Needle placement, Injection of Ropivacaine in the hepatic hilum for

    Not yet recruiting
    • Pain Control
    • Liver Cancer
    • Hepatic Hilar Nerve Block Needle placement
    • +2 more
    • (no location specified)
    Feb 23, 2021

    Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • dTACE-HAIC
    • +3 more
    • Guangzhou, Guangdong, China
      the Second Affiliated Hospital of Guangzhou Medical University
    Feb 22, 2022

    Potentially Resection, Hepatocellular Carcinoma Trial in Guangzhou (TACE-HAIC, HAIC)

    Recruiting
    • Potentially Resection
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 20, 2021

    HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

    Recruiting
    • HCC
    • DEB-TACE and HAIC
    • DEB-TACE
    • Luohe, Henan, China
    • +15 more
    Mar 28, 2023

    Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Hepatic Artery Infusion Chemotherapy
    • +3 more
    • (no location specified)
    Feb 7, 2022

    Liver Cancer Trial in Baltimore (biological, drug, procedure)

    Completed
    Has Results
    • Liver Cancer
    • bevacizumab
    • +3 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Aug 11, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    Nov 16, 2021

    Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Beijing, Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Nov 22, 2021

    Transarterial Chemoembolization, Hepatocellular Carcinoma Trial (cTACE-HAIC)

    Unknown status
    • Transarterial Chemoembolization
    • Hepatocellular Carcinoma
    • (no location specified)
    Oct 17, 2020

    Complications of Endovascular Methods in Malignant Liver Tumors

    Recruiting
    • Hepatic Cancer
    • +2 more
    • Chemoembolization
    • Chemoinfusion
    • Moscow, Moscow's Oblast, Russian Federation
      Central Clinical Hospital RZD-Medicine, Russian Federation
    Feb 17, 2021